Delivery Order SPE2DB20D3505-SPE2DB22FT8X4
- Not listed
- This federal contract award is for the delivery of WIXELA 100-50 INHUB 60S medical products to the Defense Logistics Agency (DLA). The $1,805.64 firm-fixed-price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under an existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as a primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and...
- This federal contract award is for the delivery of WIXELA 250-50 INHUB 60S pharmaceutical product to the Defense Logistics Agency (DLA), an agency within the U.S. Department of Defense (DoD). The $2,788.34 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceuticals and medical supplies to the federal government. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of WIXELA 500-50 INHUB 60S pharmaceutical products by Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to the Defense Logistics Agency (DLA). The $2,350.32 firm fixed-price delivery order has an ultimate completion date of October 29, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award is for the delivery of WIXELA 100-50 INHUB 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,391.28 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 21, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award is for the delivery of pharmaceutical products, specifically WIXELA 250-50 INHUB 60S, to the Defense Logistics Agency (DLA). The $3,147.16 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The award is not designated as a set-aside contract. It is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,454.66, is for the delivery of WIXELA 250-50 INHUB 60S medical products. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent...
- This federal contract award, valued at $1,731.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product WIXELA 500-50 INHUB 60S, with a completion date of January 28, 2022. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver WIXELA 250-50 INHUB 60S medication. The contract, valued at $1,188.55, is a firm fixed-price delivery order that runs through December 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,042.24, is for the delivery of WIXELA 250-50 INHUB 60S medical products. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
- This federal contract award is for the delivery of "WIXELA 250-50 INHUB 60S" medical supplies to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,484.34, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a wide range of pharmaceutical products and medical supplies to support the Department of Defense's military...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB22FT8X4Delivery Order
This federal contract award is for the delivery of WIXELA 250-50 INHUB 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $1,165.71 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/6/22 |